Cabozantinib combination therapy for the treatment of solid tumors: a systematic review

BACKGROUND: Cabozantinib monotherapy is approved for the treatment of several types of solid tumors. Investigation into the use of cabozantinib combined with other therapies is increasing. To understand the evidence in this area, we performed a systematic review of cabozantinib combination therapy f...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellano, Daniel, Apolo, Andrea B., Porta, Camillo, Capdevila, Jaume, Viteri, Santiago, Rodriguez-Antona, Cristina, Martin, Lidia, Maroto, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340935/
https://www.ncbi.nlm.nih.gov/pubmed/35923927
http://dx.doi.org/10.1177/17588359221108691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340935/
https://www.ncbi.nlm.nih.gov/pubmed/35923927
http://dx.doi.org/10.1177/17588359221108691

Ejemplares similares